000 01167 a2200313 4500
005 20250515121143.0
264 0 _c20080630
008 200806s 0 0 eng d
022 _a1389-2002
024 7 _a10.2174/138920008784220619
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPatocka, Jiri
245 0 0 _aPossible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease.
_h[electronic resource]
260 _bCurrent drug metabolism
_cMay 2008
300 _a332-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aCholinesterase Inhibitors
_xmetabolism
650 0 4 _aCytochrome P-450 Enzyme System
_xgenetics
650 0 4 _aHumans
650 0 4 _aHydroxylation
650 0 4 _aNootropic Agents
_xmetabolism
650 0 4 _aTacrine
_xanalogs & derivatives
700 1 _aJun, Daniel
700 1 _aKuca, Kamil
773 0 _tCurrent drug metabolism
_gvol. 9
_gno. 4
_gp. 332-5
856 4 0 _uhttps://doi.org/10.2174/138920008784220619
_zAvailable from publisher's website
999 _c17968734
_d17968734